DELETION OF BONE MARROW OR NON-BONE MARROW DERIVED RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS ATTENUATES DIABETES-ASSOCIATED ATHEROSCLEROSIS

被引：0
|
作者：
Koulis, C. [1 ]
Kanellakis, P. [1 ]
Pickering, R. J. [1 ]
Tsorotes, D. [1 ]
Thomas, M. C. [1 ]
Cooper, M. E. [1 ]
Jandeleit-Dahm, K. A. [1 ]
Allen, T. J. [1 ]
机构：
[1] Baker IDI Heart & Diabet Res Inst, Melbourne, Vic, Australia
来源：
HYPERTENSION | 2014年 / 63卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E168 / E168
页数：1
相关论文
共 50 条
  • [31] Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes
    Tan, K. C. B.
    Chow, W. S.
    Shiu, S. W. M.
    Bucala, R.
    Betteridge, D. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 294 - 294
  • [32] Advanced glycation end products in diabetes associated atherosclerosis and renal disease - Interventional studies
    Jandeleit-Dahm, KA
    Lassila, M
    Allen, TJ
    MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 : 759 - 766
  • [33] A role for advanced glycation end products in diminished bone healing in type 1 diabetes
    Santana, RB
    Xu, L
    Chase, HB
    Amar, S
    Graves, DT
    Trackman, PC
    DIABETES, 2003, 52 (06) : 1502 - 1510
  • [34] Association of Bone Turnover Markers and Advanced Glycation End Products in Type 1 Diabetes
    Vilaca, Tatiane
    Gossiel, Fatma
    Schalkwijk, Casper
    Walsh, Jennifer
    Selvarajah, Dinesh
    Eastell, Richard
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 79 - 79
  • [35] Analysis of neutrophil gelatinase-associated lipocalin, vascular endothelial growth factor, and soluble receptor for advanced glycation end-products in bone marrow supernatant in hematologic malignancies
    Cho, Chi-Hyun
    Cha, Jaehyung
    CLINICAL BIOCHEMISTRY, 2020, 80 : 19 - 24
  • [36] Methylglyoxal and Advanced Glycation End Products (AGEs): Targets for the Prevention and Treatment of Diabetes-Associated Bladder Dysfunction?
    Oliveira, Akila Lara
    de Oliveira, Mariana Goncalves
    Monica, Fabiola Zakia
    Antunes, Edson
    BIOMEDICINES, 2024, 12 (05)
  • [37] Interleukin-1 Receptor Antagonist Originating from Bone Marrow-derived Cells and Non-bone Marrow-derived Cells Helps to Suppress Arterial Inflammation and Reduce Neointimal Formation after Injury
    Isoda, Kikuo
    Akita, Koji
    Isobe, Sarasa
    Niida, Tomiharu
    Adachi, Takeshi
    Iwakura, Yoichiro
    Daida, Hiroyuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 (11) : 1208 - 1218
  • [38] The Treatment of Bone Marrow Lesions Associated with Advanced Knee Osteoarthritis: Comparing Intraosseous and Intraarticular Injections with Bone Marrow Concentrate and Platelet Products
    Centeno, Christopher
    Cartier, Cameron
    Stemper, Ian
    Dodson, Ehren
    Freeman, Michael
    Azuike, Ugochi
    Williams, Christopher
    Hyzy, Matthew
    Silva, Otono
    Steinmetz, Neven
    PAIN PHYSICIAN, 2021, 24 (03) : E279 - E288
  • [39] Bone Marrow Indoleamine 2, 3-Dioxygenase Deficiency Attenuates CKD Associated Atherosclerosis
    Chai, Biaoxin
    Cheofor, Vetalise K.
    Zeng, Lixia
    Patel, Dheer
    Keller, Max
    Roeser, Nancy F.
    Byun, Jaeman
    Mathew, Anna V.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 815 - 815
  • [40] Tlr2 on Bone Marrow and Non-Bone Marrow Derived Cells Regulates Inflammation and Organ Injury in Cooperation with Tlr4 During Resuscitated Hemorrhagic Shock
    Korff, Sebastian
    Loughran, Patricia
    Cai, Changchun
    Fan, Jie
    Elson, Greg
    Shang, Limin
    Pires, Susana Salgado
    Lee, Yi Shan
    Guardado, Jesse
    Scott, Melanie
    Billiar, Timothy R.
    SHOCK, 2016, 46 (05): : 519 - 526
12345